
aTyr Pharma, Inc. Common Stock
ATYR Real Time Price USDRecent trades of ATYR by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by ATYR's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
ATYR Revenue by Segment or Geography
New patents grants
-
Patent Title: Compositions and methods comprising anti-nrp2 antibodies Aug. 20, 2024
-
Patent Title: Therapeutic compositions comprising anti-nrp2 antibodies Nov. 07, 2023
-
Patent Title: Compositions and methods for treating lung inflammation Sep. 26, 2023
-
Patent Title: Compositions and methods comprising anti-nrp2 antibodies Nov. 22, 2022
-
Patent Title: Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities Aug. 03, 2021
-
Patent Title: Histidyl-trna synthetase-fc conjugates Jul. 27, 2021
-
Patent Title: Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities Mar. 09, 2021
-
Patent Title: Histidyl-trna synthetase-fc conjugates Jul. 14, 2020
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases Jun. 02, 2020
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-trna synthetases Feb. 18, 2020
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases Feb. 18, 2020
-
Patent Title: Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities Jan. 07, 2020
-
Patent Title: Histidyl-trna synthetase-fc conjugates Nov. 12, 2019
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases Feb. 05, 2019
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases Feb. 05, 2019
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl-trna synthetases Jan. 29, 2019
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases Jan. 15, 2019
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases Jan. 15, 2019
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases Dec. 25, 2018
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-trna synthetases Dec. 11, 2018
-
Patent Title: Histidyl-trna synthetase-fc conjugates Oct. 09, 2018
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase Jul. 24, 2018
-
Patent Title: Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities Jul. 10, 2018
-
Patent Title: Aminoacyl trna synthetases for modulating inflammation Apr. 17, 2018
-
Patent Title: Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities Feb. 20, 2018
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases Feb. 20, 2018
-
Patent Title: Pegylated aspartyl-trna synthetase polypeptides Nov. 21, 2017
-
Patent Title: Aspartyl-trna synthetases Nov. 14, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases Oct. 24, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases Oct. 17, 2017
-
Patent Title: Pegylated tyrosyl-trna synthetase polypeptides Jul. 25, 2017
-
Patent Title: Aspartyl-trna synthetase-fc conjugates Jun. 27, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases Jun. 27, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases May. 02, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases Apr. 18, 2017
-
Patent Title: Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities Mar. 28, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases Mar. 14, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases Mar. 14, 2017
-
Patent Title: Histidyl-trna synthetase-fc conjugates Mar. 07, 2017
-
Patent Title: Compositions and methods comprising glycyl-trna synthetases having non-canonical biological activities Mar. 07, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-trna synthetases Feb. 28, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases Feb. 21, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl-trna synthetases Jan. 31, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase Jan. 10, 2017
-
Patent Title: Aminoacyl trna synthetases for modulating inflammation Jan. 10, 2017
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases Dec. 27, 2016
-
Patent Title: Thrombopoietic activity of tyrosyl-trna synthetase polypeptides Nov. 22, 2016
-
Patent Title: Polypeptide structural motifs associated with cell signaling activity Sep. 27, 2016
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases Aug. 30, 2016
-
Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases Aug. 23, 2016
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ATYR
Recent picks made for ATYR stock on CNBC
ETFs with the largest estimated holdings in ATYR
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
---|
- Is $ATYR stock a Buy, Sell, or Hold?
- What is the price target for $ATYR stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
Shareholder
|
Shares Held
|
---|
- Who owns $ATYR stock?
- Who owns the most shares of $ATYR stock?
- What funds own $ATYR stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ATYR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.